Imunon Inc (IMNN)
1.33
+0.02
(+1.53%)
USD |
NASDAQ |
May 03, 16:00
1.35
+0.02
(+1.50%)
After-Hours: 20:00
Imunon Enterprise Value: -3.194M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | -3.194M |
| May 02, 2024 | -3.382M |
| May 01, 2024 | -3.382M |
| April 30, 2024 | -3.382M |
| April 29, 2024 | -2.961M |
| April 26, 2024 | -2.160M |
| April 25, 2024 | -2.160M |
| April 24, 2024 | -3.476M |
| April 23, 2024 | -3.194M |
| April 22, 2024 | -3.758M |
| April 19, 2024 | -4.698M |
| April 18, 2024 | -5.121M |
| April 17, 2024 | -4.980M |
| April 16, 2024 | -2.818M |
| April 15, 2024 | -1.878M |
| April 12, 2024 | -0.75M |
| April 11, 2024 | -1.22M |
| April 10, 2024 | -2.066M |
| April 09, 2024 | -1.126M |
| April 08, 2024 | -1.709M |
| April 05, 2024 | -0.374M |
| April 04, 2024 | -2.630M |
| April 03, 2024 | -2.630M |
| April 02, 2024 | 0.754M |
| April 01, 2024 | 2.446M |
| Date | Value |
|---|---|
| March 28, 2024 | -0.28M |
| March 27, 2024 | -2.536M |
| March 26, 2024 | -4.706M |
| March 25, 2024 | -7.237M |
| March 22, 2024 | -7.424M |
| March 21, 2024 | -7.893M |
| March 20, 2024 | -8.364M |
| March 19, 2024 | -8.119M |
| March 18, 2024 | -7.941M |
| March 15, 2024 | -7.612M |
| March 14, 2024 | -8.176M |
| March 13, 2024 | -7.508M |
| March 12, 2024 | -6.954M |
| March 11, 2024 | -6.397M |
| March 08, 2024 | -6.297M |
| March 07, 2024 | -6.484M |
| March 06, 2024 | -6.454M |
| March 05, 2024 | -7.148M |
| March 04, 2024 | -6.531M |
| March 01, 2024 | -6.390M |
| February 29, 2024 | -4.980M |
| February 28, 2024 | -6.484M |
| February 27, 2024 | -9.022M |
| February 26, 2024 | -9.961M |
| February 23, 2024 | -10.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-24.81M
Minimum
Sep 23 2022
193.65M
Maximum
Feb 22 2021
14.18M
Average
8.486M
Median
Jan 03 2022
Enterprise Value Benchmarks
| Avalo Therapeutics Inc | 7.435M |
| iBio Inc | 16.80M |
| Ocugen Inc | 305.59M |
| Petros Pharmaceuticals Inc | -0.0096M |
| Moderna Inc | 39.38B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.888M |
| Total Expenses (Quarterly) | 5.968M |
| EPS Diluted (Quarterly) | -0.52 |
| Earnings Yield | -163.9% |
| Normalized Earnings Yield | -319.39 |